Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: In situaromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer

Figure 1

Representative pictures of immunohistochemical aromatase staining of primary breast tumor tissue with the antibody #677. (A) WS with high level of aromatase expression. (B) TMA with high level of aromatase expression. (C) WS with low level of aromatase expression. (D) TMA with low level of aromatase expression. (E) WS from a tumor showing heterogeneity in carcinoma cell staining intensity scored as high expression (score value 9). (F) A TMA illustrating discordant low intensity score (score value 1).

Back to article page